Satoshi Yoda

Also affiliated with Massachusetts General Hospital, Tango Therapeutics (United States)

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 7 papers. Top paper: “Deregulation of histone lysine methyltransferases contributes to oncogenic transformation of human bronchoepithelial cells”.

Deregulation of histone lysine methyltransferases contributes to oncogenic transformation of human bronchoepithelial cells

Cancer Cell International(2008)10.1186/1475-2867-8-15

N/A

0.756DataRank · unranked

153 citations

Kenzo Soejima, Hiroyuki Yasuda, Ichiro Kawada, Ichiro Nakachi, Satoshi Yoda +3 more

DrugMap: A quantitative pan-cancer analysis of cysteine ligandability

Cell(2024)10.1016/j.cell.2024.03.027

N/A

0.686DataRank · unranked

96 citations

Harrison B. Chong, Siwen Zhang, Tzu-Yi Yang, Matthew J. Lazarov, Stefan Harry +66 more

NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK-Mutant Oncoproteins, Including Lorlatinib-Resistant Compound Mutations

Cancer Discovery(2024)10.1158/2159-8290.cd-24-0231

N/A

0.587DataRank · unranked

49 citations

Joshua C. Horan, Anupong Tangpeerachaikul, Aurélie Swalduz, Augusto Valdivia, Melissa L. Johnson +23 more

GUK1 activation is a metabolic liability in lung cancer

Cell(2025)10.1016/j.cell.2025.01.024

N/A

0.449DataRank · unranked

19 citations

Kiran Kurmi, Yutong Dai, Ishita Dhiman, Shakchhi Joshi, Brandon M. Gassaway +21 more

DrugMap: A quantitative pan-cancer analysis of cysteine ligandability

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.10.20.563287

N/A

0.330DataRank · unranked

8 citations

Harrison B. Chong, Siwen Zhang, Matthew J. Lazarov, Stefan Harry, Michelle Maynard +64 more

Structural and functional analysis of lorlatinib analogs reveals roadmap for targeting diverse compound resistance mutations in ALK-positive lung cancer

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.07.16.452681

N/A

0DataRank · unranked

2 citations

Ted W. Johnson, Ibiayi Dagogo‐Jack, Mari Mino–Kenudson, Theodore R. Johnson, Ping Wei +16 more

Alginate-based 3D cancer cell culture for therapeutic response modeling

STAR Protocols(2021)10.1016/j.xpro.2021.100391

N/A

0DataRank · unranked

10 citations

Samar Ghorbanpoor, Satoshi Yoda, Xiao Pan, Giovanna Stein Crowther, Xunqin Yin +5 more